We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

131 hedge funds and large institutions have $84.1M invested in ImmunityBio in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 11

12% more funds holding

Funds holding: 117 → 131 (+14)

10% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 30

4% less call options, than puts

Call options by funds: $4.51M | Put options by funds: $4.7M

1.5% less ownership

Funds ownership: 8.97% → 7.47% (-1.5%)

23% less capital invested

Capital invested by funds: $109M → $84.1M (-$24.6M)

Holders
131
Holders Change
+14
Holders Change %
+11.97%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
33
Reduced
30
Closed
11
Calls
$4.51M
Puts
$4.7M
Net Calls
-$190K
Net Calls Change
-$2.05M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$8.72M
2
AC
Armistice Capital
New York
+$6.98M
3
BlackRock
BlackRock
New York
+$2.64M
4
CS
Credit Suisse
Switzerland
+$1.04M
5
Group One Trading
Group One Trading
Illinois
+$897K

Top Sellers

1
DFCM
Dark Forest Capital Management
Puerto Rico
-$566K
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$537K
3
Jane Street
Jane Street
New York
-$295K
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$193K
5
State Street
State Street
Massachusetts
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
126
PSI Advisors
Florida
$592 – – –
Federated Hermes
127
Federated Hermes
Pennsylvania
$439 -$31.1K -15,495 -98%
Nisa Investment Advisors
128
Nisa Investment Advisors
Missouri
$394 +$468 +233 New
CBT
129
Central Bank & Trust
Kentucky
$135 – – –
FGAM
130
Financial Gravity Asset Management
Texas
$7 -$2 -1 -33%
DFCM
131
Dark Forest Capital Management
Puerto Rico
– -$566K -203,659 Closed
Balyasny Asset Management
132
Balyasny Asset Management
Illinois
– -$537K -193,285 Closed
Jane Street
133
Jane Street
New York
– -$295K -146,732 Closed
Wolverine Trading
134
Wolverine Trading
Illinois
– -$64.6K -32,178 Closed
JF
135
Jump Financial
Illinois
– -$62.9K -22,635 Closed
Ameriprise
136
Ameriprise
Minnesota
– -$62.3K -22,400 Closed
Man Group
137
Man Group
United Kingdom
– -$28.5K -10,242 Closed
AWP
138
Ascent Wealth Partners
New York
– -$27.8K -10,000 Closed
WAM
139
Worth Asset Management
Texas
– -$4.31K -1,550 Closed
Parallax Volatility Advisers
140
Parallax Volatility Advisers
California
– -$826 -297 Closed
NA
141
NewEdge Advisors
Louisiana
– -$695 -250 Closed
C
142
Covestor
United Kingdom
– -$10 -5 -12%
2 3 4 5
6

IBRX Hedge Fund Activity: Q3 2023 in Review

131 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q3 2023, worth a combined $84.1M — down 23% from $109M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IBRX positions and 11 closed out — a net gain of 18 holders — while 33 added to existing stakes and 30 trimmed.

The largest buyer was Vanguard Group, adding an estimated $8.72M. The largest seller was Dark Forest Capital Management, exiting entirely with an estimated $566K sold.

  • 131 institutional investors held ImmunityBio (IBRX) as of Q3 2023, up from 117 in Q2 2023.
  • Funds reported $84.1M of ImmunityBio stock for Q3 2023, down 23% quarter-over-quarter.
  • 29 funds opened new ImmunityBio positions in Q3 2023 and 11 closed out, a net change of +18 holders.
  • The largest ImmunityBio buyer in Q3 2023 was Vanguard Group, an estimated $8.72M added.
  • The largest ImmunityBio seller in Q3 2023 was Dark Forest Capital Management, an estimated $566K sold.

Based on aggregated 13F filings for Q3 2023.